Careteq Ltd. · ASX:CTQ

Careteq — Shareholder Meeting (November 2024)

14 slides from Careteq's shareholder meeting presentation, Nov 28, 2024

  1. Slide 1: 2024 AGM Presentation

    For personal use only 2024 AGM PRESENTATION Constant care, everywhere November 2024

  2. Slide 2: Disclaimer and Important Notices

    Disclaimer and Important Notices For personal use only 2024 AGM Presentation | 5

  3. Slide 3: AGM agenda

    AGM agenda Executive Chairman presentation For personal use only Careteq overview MARK SIMARI Executive Chairman Updates • Over 16 years’ Board experience in a diverse range of organisations. • Co-Founded and served as Managing Director of Paragon Care (ASX: PGC) from 2008 to 2018, leading its Group

  4. Slide 4: Company overview

    Company overview For personal use only We are Australia’s Medication Management (Aged Care) Medication Management (Home Care) leading medication management business. SERVICES: MARKETPLACE SOFTWARE: Australia’s largest provider of medication N Matching GPs’ Home Medication Review We provide clinical

  5. Slide 5: The problem we solve

    The problem we solve For personal use only Medication misadventure Medication-related harm is a critical issue in healthcare, encompassing adverse drug 1 in 2 88% 66% reactions, medication errors, and complications that jeopardise patient safety and lead to increased healthcare costs. People aged 65

  6. Slide 6: How we solve it

    How we solve it For personal use only The Medication Our Accredited Pharmacists conduct Medication Management Review Management Reviews to assess a patient's medication process helps to: regimen and ensure it's appropriate and safe: 01. 02. Review patient's medications Evaluate the safety and Reduce

  7. Slide 7: Key stakeholders and business model

    Patient (has potential medication issue) Key stakeholders and business model Residential Aged Home Care Clients For personal use only Care Facilities and/or (RMMRs & QUM)1 Providers (HMRs) GPs (refers patient for medication review – Medicare Our value proposition: reimbursement) Reduction in medicat

  8. Slide 8: Market growth

    Number of home care recipients + waitlist, FY18 – FY231 Market growth For personal use only The Australian home care market is experiencing rapid expansion, driven by an ageing population and government policies prioritising "ageing in place." From FY18 to FY23, the number of people Government fundi

  9. Slide 9: FY24 summary achievements

    ACHIEVEMENT 1: ACHIEVEMENT 2: Divestment of Sofihub Acquisition of remaining 45% of EHS FY24 Summary: Strategically divested Sofihub for $0.6m to focus on profitable Summary: Now 100% owned. Full ownership enables Careteq to maximise EHS’s value, achievements medication management. This move is driv

  10. Slide 10: Financial summary (continuing operations)

    Financial summary (continuing operations) FY24 vs. FY23 For personal use only Strong Revenue growth: Revenue1 growth 8,000 Revenue1 increased 45% to $7.2m, up from $5.0m in FY23. 6,000 Improving Profitability: 4,000 Significant narrowing of EBITDA loss1 in FY24 ($0.8m) vs FY23 ($2.1m) and NPAT loss1

  11. Slide 11: EHS and HMR Referrals Synergies

    EHS and HMRR Referrals Synergies For personal use only Dedicated and laser focused 01 02 medication management and Integrated medication Expanded reach clinical governance company management platform and service offering Combining EHS’s residential services with EHS’s clinical governance expertise c

  12. Slide 12: FY25 – repositioning for growth & profitability

    01 During Q1-FY25, the board executed on its strategic plan as follows: FY25 – • Sold loss-making assistive living technology business • Acquired the remaining shares in Embedded Health Solutions (EHS), now 100% owned repositioning • Sales and operational synergies between EHS and HMR Referrals comm

  13. Slide 13: Corporate overview

    Corporate BOARD OF DIRECTORS overview For personal use only CAPITAL STRUCTURE 235,547,292 MARK SIMARI Executive Chairman BRETT CHEONG Non-Executive Director STEPHEN MUNDAY Non-Executive Director Shares on issue Over 16 years’ Board experience in Over 40 years of background Over 40 years business exp

  14. Slide 14: Thank You

    For personal use only Thank You MARK SIMARI CORPORATE ADDRESS Executive Chairman CARETEQ, Level 10, 99 Queen Street mark.simari@careteq.com.au Melbourne, 3000 2024 AGM Presentation | 17

Careteq — Shareholder Meeting (November 2024) on 6ix